When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome de Wolff-Parkinson-White

Última revisão: 13 Sep 2025
Última atualização: 24 Sep 2024

Resumo

Definição

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • taquicardia reentrante atrioventricular (TRAV)
Full details

Other diagnostic factors

  • palpitações
  • tontura
  • dispneia
  • dor torácica
  • fibrilação atrial
  • flutter atrial
  • anomalias cardíacas congênitas
  • morte súbita cardíaca
  • síncope e pré-síncope
  • taquicardia na gestação
Full details

Risk factors

  • Anomalia de Ebstein
  • cardiomiopatia hipertrófica
  • prolapso da valva mitral
  • defeito do septo atrial
  • defeito do septo ventricular
  • transposição dos grandes vasos
  • coarctação aórtica
  • dextrocardia
  • divertículos do seio coronário
  • aneurismas atriais à direita e esquerda
  • rabdomiomas cardíacos
  • Síndrome de Marfan
  • ataxia de Friedreich
  • história familiar
Full details

Diagnostic tests

1st tests to order

  • eletrocardiograma (ECG) de 12 derivações
Full details

Tests to consider

  • ecocardiograma
  • teste ergométrico
  • estudo eletrofisiológico
Full details

Treatment algorithm

INITIAL

instável: PA <90/60 mmHg, sinais de hipoperfusão sistêmica ou fibrilação atrial instável

ACUTE

estável: taquicardia (reciprocante atrioventricular ortodrômica) de complexo estreito

estável: taquicardia (reciprocante atrioventricular ortodrômica) de complexo largo

estável: taquicardia pré-excitada devido à fibrilação atrial ou flutter atrial

estável: taquicardia pré-excitada devido à taquicardia atrial

ONGOING

após o tratamento do quadro agudo: assintomáticos

após o tratamento do quadro agudo: sintomáticos

Contributors

Authors

Hugh Calkins, MD

Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

HC declares that he is a consultant for Medtronic, Biosense Webster, Abbott, and Boston Scientific.

Acknowledgements

We would like to acknowledge our cardiology expert panel member, Dr Fred Kusumoto, for his contribution to this topic.

Professor Hugh Calkins would like to gratefully acknowledge Dr David Frankel, Dr Mithilesh K. Das, and Dr Douglas P. Zipes, previous contributors to this topic.

Disclosures

DF, MKD, and DPZ declare that they have no competing interests.

Peer reviewers

Nicolas Palaskas, MD, FACC

Assistant Professor

University of Texas MD Anderson Cancer Center

Houston

TX

Disclosures

NP declares that he has no competing interests.

Joseph E. Marine, MD

Associate Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

JEM declares that he has no competing interests.

Suneet Mittal, MD

Director

Electrophysiology Laboratory

The St. Luke's-Roosevelt Hospital Center

New York

NY

Disclosures

SM declares that he has no competing interests.

Andrew Turley, MB ChB

Cardiology Specialist Registrar

The James Cook University Hospital

Middlesbrough

UK

Disclosures

AT declares that he has no competing interests.

Steve Hsu, MD

Associate Professor

Department of Medicine

Division of Cardiology

University of Florida College of Medicine

Jacksonville

FL

Disclosures

SH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Full text  Abstract

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.Full text  Abstract

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27-e115.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Síndrome de Wolff-Parkinson-White images
  • Differentials

    • Via atriofascicular
    • Síndrome de Lown-Ganong-Levine
    • Via nodofascicular
    More Differentials
  • Guidelines

    • 2023 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    More Guidelines
  • Patient information

    Fibrilação atrial: quais são as opções de tratamento?

    Fibrilação atrial: o que é?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer